Rani Therapeutics Share Price (NASDAQ: RANI)
$0.51
Last updated on
Check the interactive Rani Therapeutics Stock chart to analyse performance
Rani Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$0.51Today's High:$0.53
0.0%
Downside
Day's Volatility :3.77%
Upside
3.77%
- 52 Weeks Low:$0.3952 Weeks High:$3.75
24.12%
Downside
52 Weeks Volatility :89.68%
Upside
86.4%
Rani Therapeutics Stock Returns
Rani Therapeutics Holdings Inc Key Stats
Check Rani Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Rani Therapeutics Stock including INR - Dollar returns
The Rani Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rani Therapeutics investment value today
Current value as on today
₹22,514
Returns
Returns from Rani Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Rani Therapeutics Stock
Global Institutional Holdings in Rani Therapeutics Holdings Inc
Name
Holdings %
Armistice Capital, LLC
8.03%
Vanguard Group Inc
2.04%
United Services Automobile Association
0.77%
Takeda Pharmaceutical Co Ltd
0.52%
Geode Capital Management, LLC
0.50%
KESTRA PRIVATE WEALTH SERVICES, LLC
0.40%
Analyst Recommendation on Rani Therapeutics Stock
Buy
92%Buy
7%Hold
0%Sell
Based on 13 Wall street analysts offering stock ratings for Rani Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Rani Therapeutics Share Price Target
What analysts predicted
Upside of 1419.61%
Target:
$7.75
Current:
$0.51
Rani Therapeutics share price target is $7.75, a slight Upside of 1419.61% compared to current price of $0.51 as per analysts' prediction.
Rani Therapeutics Stock Insights
Price Movement
In the last 7 days, RANI stock has moved down by -18.3%RANI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 154.0%RANI vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 206.9%Price to Sales
ForRANI every $1 of sales, investors are willing to pay $14.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Rani Therapeutics Technicals Summary
Sell
Neutral
Buy
Rani Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Rani Therapeutics Holdings Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -3.48% | -65.31% | -82.77% | -94.57% | -95.36% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.54 | -11.88 | -0.94 | NA | -0.14 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $41.1M | -95.36% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Rani Therapeutics Holdings Inc
Key Management of Rani Therapeutics Holdings Inc
Important FAQs about investing in RANI Stock from India :
What is Rani Therapeutics share price today?
Rani Therapeutics share price today is $0.51 as on at the close of the market. Rani Therapeutics share today touched a day high of $0.53 and a low of $0.51.
What is the 52 week high and 52 week low for Rani Therapeutics share?
Rani Therapeutics share touched a 52 week high of $3.75 and a 52 week low of $0.39. Rani Therapeutics stock price today i.e. is closed at $0.51, lower by 86.4% versus the 52 week high.
How to invest in Rani Therapeutics Stock (RANI) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Rani Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rani Therapeutics Shares that will get you 2.9412 shares as per Rani Therapeutics share price of $0.51 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Rani Therapeutics Stock (RANI) from India?
Indian investors can start investing in Rani Therapeutics (RANI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Rani Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Rani Therapeutics share’s latest price of $0.51 as on August 30, 2025 at 1:29 am IST, you will get 19.6078 shares of Rani Therapeutics. Learn more about
fractional shares .
What are the returns that Rani Therapeutics has given to Indian investors in the last 5 years?
Rani Therapeutics stock has given -95.36% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%